• English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • français 
    • English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • Ouvrir une session
Voir le document 
  •   Accueil de DSpace
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Voir le document
  •   Accueil de DSpace
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Voir le document
JavaScript is disabled for your browser. Some features of this site may not work without it.
Tout DSpace
  • Communautés & Collections
  • Par date de publication
  • Auteurs
  • Titres
  • Sujets

Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)

Thumbnail
Auteur
Sacco S., Merki-Feld G.S., Ægidius K.L., Bitzer J., Canonico M., Kurth T., Lampl C., Lidegaard Ø., Anne MacGregor E., MaassenVanDenBrink A., Mitsikostas D.-D., Nappi R.E., Ntaios G., Sandset P.M., Martelletti P., on behalf of the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
Date
2017
Language
en
DOI
10.1186/s10194-017-0815-1
Sujet
contraceptive agent
estrogen
ethinylestradiol
oral contraceptive agent
Article
brain ischemia
cardiovascular risk
clinical decision making
coronary risk
disease association
drug safety
female
hormonal contraception
human
medical society
migraine
migraine with aura
prescription
priority journal
randomized controlled trial (topic)
risk assessment
risk factor
systematic review
brain ischemia
cerebrovascular accident
complication
consensus
migraine
migraine with aura
reproductive health
risk
Brain Ischemia
Consensus
Contraceptives, Oral, Combined
Contraceptives, Oral, Hormonal
Female
Humans
Migraine Disorders
Migraine with Aura
Reproductive Health
Risk
Risk Factors
Stroke
Springer-Verlag Italia s.r.l.
Afficher la notice complète
Résumé
Several data indicate that migraine, especially migraine with aura, is associated with an increased risk of ischemic stroke and other vascular events. Of concern is whether the risk of ischemic stroke in migraineurs is magnified by the use of hormonal contraceptives. As migraine prevalence is high in women of reproductive age, it is common to face the issue of migraine and hormonal contraceptive use in clinical practice. In this document, we systematically reviewed data about the association between migraine, ischemic stroke and hormonal contraceptive use. Thereafter a consensus procedure among international experts was done to develop statements to support clinical decision making, in terms of cardiovascular safety, for prescription of hormonal contraceptives to women with migraine. Overall, quality of current evidence regarding the risk of ischemic stroke in migraineurs associated with the use of hormonal contraceptives is low. Available data suggest that combined hormonal contraceptive may further increase the risk of ischemic stroke in those who have migraine, specifically migraine with aura. Thus, our current statements privilege safety and provide several suggestions to try to avoid possible risks. As the quality of available data is poor further research is needed on this topic to increase safe use of hormonal contraceptives in women with migraine. © 2017, The Author(s).
URI
http://hdl.handle.net/11615/78647
Collections
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ. [19735]

Related items

Showing items related by title, author, creator and subject.

  • Thumbnail

    Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: A consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH) 

    Sacco S., Merki-Feld G.S., Ægidius K.L., Bitzer J., Canonico M., Gantenbein A.R., Kurth T., Lampl C., Lidegaard Ø., Anne Macgregor E., Maassenvandenbrink A., Mitsikostas D.-D., Nappi R.E., Ntaios G., Paemeleire K., Sandset P.M., Terwindt G.M., Vetvik K.G., Martelletti P. (2018)
    We systematically reviewed data about the effect of exogenous estrogens and progestogens on the course of migraine during reproductive age. Thereafter a consensus procedure among international experts was undertaken to ...
  • Thumbnail

    Serum Homocysteine, Pyridoxine, Folate, and Vitamin B12 Levels in Migraine: Systematic Review and Meta-Analysis 

    Liampas I., Siokas V., Mentis A.-F.A., Aloizou A.-M., Dastamani M., Tsouris Z., Aslanidou P., Brotis A., Dardiotis E. (2020)
    Background: Migraine, especially migraine with aura (MA), has been linked to increased risk for ischemic cerebrovascular disease. The possible role of elevated serum homocysteine (Hcy, a cause of thrombophilia) in migraine ...
  • Thumbnail

    Serum lipid abnormalities in migraine: A meta-analysis of observational studies 

    Liampas I., Mylonas K.S., Brotis A., Dervenis P., Siokas V., Mentis A.-F.A., Dastamani M., Aloizou A.-M., Tsouris Z., Aslanidou P., Bakoyiannis C., Dardiotis E. (2021)
    Background: The association of migraine with vascular comorbidities is long-established. The contribution of the “traditional” cardiovascular risk factors to this connection remains unclear. Objective: To determine-quantify ...
htmlmap 

 

Parcourir

Tout DSpaceCommunautés & CollectionsPar date de publicationAuteursTitresSujetsCette collectionPar date de publicationAuteursTitresSujets

Mon compte

Ouvrir une sessionS'inscrire
Help Contact
DepositionAboutHelpContactez-nous
Choose LanguageTout DSpace
EnglishΕλληνικά
htmlmap